The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EBMT 2017 | Cellular therapy: a key part of EBMT 2017
Nicolaus Kröger, MD, from the University Medical Center Hamburg-Eppendorf, Hamburg, Germany, speaks about how the rising field of cellular therapy has been one of the essential parts of the 2017 EBMT meeting. He highlights debates about how to avoid relapse after stem cell transplantation in hematological malignancies, as well as the rising field of cell therapy. Recorded at the 2017 annual meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Marseille, France.
